Could an ultrasound replace MRI for heart monitoring?
NCT ID NCT05186415
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a contrast dye during 3D ultrasound can accurately measure the size and function of the right heart chamber in people who had surgery for congenital heart disease. 25 participants received an injection of Lumason (an ultrasound contrast agent) and then had a 3D echocardiogram. The results were compared to standard cardiac MRI measurements to see if the ultrasound method is reliable enough for routine use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sulfur hexafluoride lipid microspheres (Lumason)
What this could lead to
If successful, this could provide a faster, cheaper, and safer way to monitor heart function in people with repaired congenital heart disease, reducing the need for frequent MRIs.
What could go wrong
This is a small, early-phase study with only 25 participants, so results may not apply to everyone. The contrast agent also carries a small risk of allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETRALOGY OF FALLOT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nemours Childrens Hospital
Wilmington, Delaware, 19803, United States